Filing Details

Accession Number:
0000899243-22-028654
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-15 17:03:50
Reporting Period:
2022-08-11
Accepted Time:
2022-08-15 17:03:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1861113 Daniel Niedzwiecki C/O Lantheus Holdings, Inc.
331 Treble Cove Road
North Billerica MA 01862
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-08-11 3,000 $82.66 68,143 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2022.